US Stock MarketDetailed Quotes
TENX Tenax Therapeutics
- 4.7200
- -0.1300-2.68%
Trading Nov 22 12:08 ET
16.09MMarket Cap-361P/E (TTM)
4.8800High4.7200Low18.27KVolume4.8800Open4.8500Pre Close87.60KTurnover0.69%Turnover RatioLossP/E (Static)3.41MShares33.440052wk High0.17P/B12.48MFloat Cap2.770052wk Low--Dividend TTM2.64MShs Float21599978.4000Historical High--Div YieldTTM3.30%Amplitude2.7700Historical Low4.7950Avg Price1Lot Size
About Tenax Therapeutics Company
Tenax Therapeutics, Inc. is a pharmaceutical company engaged in the development and commercialization of products for cardiovascular and pulmonary diseases. The company was founded on May 26, 1967 and is headquartered in Chapel Hill, NC.
Company Profile
SymbolTENX
Company NameTenax Therapeutics
Listing DateJan 15, 2010
Founded1967
CEOMr. Christopher T. Giordano
MarketNASDAQ
Employees6
Fiscal Year Ends12-31
Address101 Glen Lennox Drive,Suite 300
CityChapel Hill
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27517
Phone1-919-855-2100
Websitehttp://www.tenaxthera.com
Company Executives
- Name
- Position
- Salary
- Christopher T. Giordano
- Director, President and Chief Executive Officer
- 644.77K
- Lawrence R. Hoffman
- Interim Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Stuart Rich, M.D.
- Director and Chief Medical Officer
- 481.22K
- Gerald T. Proehl
- Chairman of the Board
- 88.50K
- Robyn M Hunter
- Independent Director
- 65.00K
- Dr. Declan Doogan, M.D.
- Independent Director
- 48.50K
- Dr. June S. Almenoff, F.A.C.P.,M.D.,PhD
- Independent Director
- 59.50K
- Dr. Michael Harvey Davidson, M.D.
- Independent Director
- 57.50K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data